跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XILONIBSA Solution for Injection 2% 1:80000 - HSA Drug Approval Details
Approvals
/
HSA
/
XILONIBSA Solution for Injection 2% 1:80000
Approved
THERAPEUTIC
XILONIBSA Solution for Injection 2% 1:80000
Laboratorios Inibsa, S.A.
🇸🇬 Health Sciences Authority
Approval Date
Jun 11, 2012
Approval ID
3137439db708f955
Company
Laboratorios Inibsa, S.A.
Type
Therapeutic
Approval Details
Approval Id
3137439db708f955
Drug Name
XILONIBSA Solution for Injection 2% 1:80000
Product Name
XILONIBSA Solution for Injection 2% 1:80000
Approval Number
SIN14157P
Approval Date
2012-06-11
Registrant
FONDACO PTE LTD
Licence Holder
FONDACO PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION
Route Of Administration
SUBMUCOSAL
Atc Code
N01BB52
Atc Item Name
lidocaine, combinations
Pharma Manufacturer Name
FONDACO PTE LTD
Company Detail Path
/organization/fondaco-pte-ltd
Active Ingredients
Lidocaine hydrochloride
20.00mg/ml
Adrenaline tartrate 0.02274mg/ml eqv Adrenaline
0.0125mg/ml
Adrenaline tartrate 0.02274mg/ml eqv Adrenaline
0.0125mg/ml
Lidocaine hydrochloride
20.00mg/ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 11, 2012
Approval ID
3137439db708f955
Type
Therapeutic
Back to HSA Approvals
